Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00081315

Public ClinicalTrials.gov record NCT00081315. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 7, 2026, 12:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomized, Double-Blind, Multicenter Trial of Subcutaneous Amifostine (Ethyol®) Versus Placebo in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer

Study identification

NCT ID
NCT00081315
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
130 participants

Conditions and interventions

Interventions

  • Amifostine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2003
Primary completion
Not listed
Completion
Jul 31, 2006
Last update posted
Aug 20, 2007

2003 – 2006

United States locations

U.S. sites
24
U.S. states
13
U.S. cities
24
Facility City State ZIP Site status
Cedars Sanai Los Angeles California 90048
Radiation Oncology Center Sacramento California 95816
The Center for Cancer Care Torrington Connecticut 06790
Florida Wellcare Alliance Inverness Florida 34452
Florida Community Cancer Center New Port Richey Florida 34652
Ormand Memorial Cancer Center Ormand Beach Florida 32174
Sarasota Memorial Hospital Sarasota Florida 34239
University Community Hospital-Center for Cancer Care Tampa Florida 33613
University of Kentucky Lexington Kentucky 40536-0293
St. Agnes Health Care Baltimore Maryland 21229
Center for Cancer & Blood Disorders Bethesda Maryland 20817
Chesapeake Oncology-Hematology Associates Glen Burnie Maryland 21061
St. John's Medical Research Springfield Missouri 65807
Cooper University Hospital Camden New Jersey 08103
Long Island Jewish Medical Center New Hyde Park New York 11040
Beth Israel Hospital New York New York 10003
Upstate NY Cancer R&E Foundation Rochester New York 14623
New Hanover Radiation Wilmington North Carolina 28401
Cancer Center of Upper Delaware Valley Milford Pennsylvania 18337
Montgomery Cancer Center Norristown Pennsylvania 19401
Charleston Cancer Center Charleston South Carolina 29406
The Center for Radiation Oncology Danville Virginia 24541
Providence Everett Medical Center Everett Washington 98201
Valley Medical Center Renton Washington 98055

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00081315, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 20, 2007 · Synced May 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00081315 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →